EVFM — Evofem Biosciences Share News
0.000.00%
Last trade - 00:00- $0.83m
- $59.92m
- $20.18m
Evofem slumps on imminent Nasdaq delisting
Brief: Evofem Biosciences Received A Written Notice From Nasdaq That It Has Determined To Delist Co's Securities
U.S. STOCKS ON THE MOVE-Energy firms, Retail chatter, MoneyGram
U.S. STOCKS ON THE MOVE-Big banks, Beyond Meat, Cinemark
U.S. STOCKS ON THE MOVE-Atlassian, Chegg
U.S. STOCKS ON THE MOVE-DoorDash, Lyft, Carvana
Evofem Biosciences jumps as contraceptive Phexxi's sales surge
Brief: Evofem Biosciences Announces Strong Q2 Results And Affirms 2022 Guidance
Brief: Evofem Biosciences Strengthens Board Of Directors
Evofem gains as study of gel in sexually transmitted infections nears end
Brief: Evofem Biosciences Announces Completion Of Last Subject Last Visit (Lslv) In Registrational Phase 3 "Evoguard" Trial Evaluating Phexxi® For The Prevention Of Chlamydia And Gonorrhea In Women
Evofem Biosciences gains on media partnership for contraceptive gel
Brief: Evofem Partners With A360 Media To Support Phexxi Prescription Growth
Short sellers flock to women contraception firm Evofem post abortion ruling - S&P Global
U.S. abortion ruling ignites retail interest in women contraceptive makers - Vanda
Brief: Evofem Strengthens Phexxi® Intellectual Property With New Composition Of Matter Patent From Uspto
U.S. STOCKS ON THE MOVE-Netflix, Playtika, Shopify, Li Auto
U.S. STOCKS ON THE MOVE-Walgreens Boots Alliance, Velodyne Lidar, U.S. banks
U.S. STOCKS ON THE MOVE-Snowflake, Nike, oil companies